Merck (BUE:MRK) Long-Term Debt

: ARS12,159,563 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

Merck's Long-Term Debt for the quarter that ended in Dec. 2023 was ARS12,159,563 Mil.

Merck's quarterly Long-Term Debt increased from Jun. 2023 (ARS8,177,280 Mil) to Sep. 2023 (ARS11,888,502 Mil) and increased from Sep. 2023 (ARS11,888,502 Mil) to Dec. 2023 (ARS12,159,563 Mil).

Merck's annual Long-Term Debt increased from Dec. 2021 (ARS3,099,383 Mil) to Dec. 2022 (ARS4,819,099 Mil) and increased from Dec. 2022 (ARS4,819,099 Mil) to Dec. 2023 (ARS12,159,563 Mil).

Merck Long-Term Debt Historical Data

The historical data trend for Merck's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

1,359,012.57

2,063,796.73

3,099,383.04

4,819,099.12

12,159,563.01

Merck Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Debt																4,819,099.12	5,546,018.83	8,177,279.94	11,888,501.73	12,159,563.01

Merck (BUE:MRK) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Merck Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Merck's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck (BUE:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BUE:MRK) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany MRK:Chile MRCK34:Brazil MRK:Austria

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.